Who are Iridia's investors?

Iridia's investors include Connecticut Innovations, Duke Capital Partners, Longley Capital, LifeSci Venture Partners, Prime Movers Lab.

Iridia

5 known investors

Find your way into Iridia

Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.

Biotech Deep Tech New Materials

Investors · 5

Connecticut InnovationsNew Haven · $500K – $2M

Duke Capital PartnersDurham

Longley CapitalSan Diego

LifeSci Venture PartnersreportedNew Yorkvia Paul Yook · inferred

Prime Movers Labreported · 2 sourcesJackson · $2M – $30M

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BMar 2021
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 4

by search overlap

SoundCloud7 shared keywordsAudio distribution and music-sharing platform for artists and creators.

Astadia6 shared keywordsAstadia helps organizations migrate mainframe workloads to modern computing platforms through legacy modernization and managed services.

Ideracorp5 shared keywordsIdera, Inc. develops B2B software tools for technical decision-making and business operations. The company serves software developers and IT professionals through a portfolio of brands focused on business process modeling, IoT, and test management.

Idera3 shared keywordsIDERA provides data management and productivity tools for technical teams managing complex data environments across on-premises, cloud, and hybrid platforms. The company serves enterprise customers seeking to minimize risk and optimize data lifecycle management.

Companies competing with Iridia for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2022	$255K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Iridia Embarks on Historic Mission to Send Bitcoin, Solana, and Ethereum to Moon - StorageNewsletterstoragenewsletter.com · Jan 2025

Iridia Raises $6 Million and Now Total at $40 Million - StorageNewsletterstoragenewsletter.com · Dec 2021

Iridia Raises $6 Million in Follow-on Equity Funding for Development of Industry’s First DNA-based Memory Chipsglobenewswire.com · Dec 2021

Iridia Raises $24 Million in Series B Fundingglobenewswire.com · Mar 2021

Frequently asked questions

What does Iridia do?: Iridia develops Molecular Avatar Technology that embeds unalterable molecular identities and custom data (text, image, audio, or video) into physical products and materials such as paints, coatings, plastics, and liquids. The technology is aimed at brands seeking product authentication, traceability, and anti-counterfeiting without changing a product's appearance or function.
Who are Iridia's investors?: Iridia's investors include Connecticut Innovations, Duke Capital Partners, Longley Capital, LifeSci Venture Partners, Prime Movers Lab.